ARCHIVES

“Significant changes should be made to reduce redundancy, streamline operations, promote collaboration, and optimize productivity.”

This article is from The Cancer Letter archive.

Vol. 21 No. 28 | July 14, 1995

Download PDF Visit The Full Archive

Related Articles

NCI Extramural Programs: NCAB Approves Guidelines for Cancer Center Grants

March 7, 1997

Cancer Groups Endorse Richard Pazdur for Head of FDA’s New Office of Oncology Drug Products. Five Candidates Are In the Running for the Job, Sources Said.

February 18, 2005

Studies Are Demonstrating Effectiveness of Drug Combinations As Adjuvant Therapy; NCI Will Support New Clinical Trials

April 5, 1974

Talking Back: FDA Faces Challenges Over Avastin & Prostate Cancer Prevention

January 21, 2011

French Cancer Group Vow to Spend More On Cancer Research

January 12, 1996

In Brief: NCFA Offers Grants For Research On Impact Of DRGs; ACCC Leaders Dispute HCFA Chief

March 8, 1985